Breaking News from Maui Derm: Research Supports the Safety and Efficacy of Delgocitinib in CHE
Delgocitinib cream continues to perform well in chronic hand eczema (CHE), with limited systemic exposure, according to two studies presented at the 2024 Maui Dermatology conference. Leo Pharma’s Delgocitinib is an investigational topical pan–Janus kinase inhibitor that inhibits activation of the JAK-STAT pathway. In one study, researchers reported significant improvements in both clinician-assessed (Investigator Global Assessment or […]